$152.25 +3.13 (2.10%) Anacor Pharmaceuticals Inc - NASDAQ

Aug. 4, 2015 | 04:00 PM
Key Statistics
Last Trade: 152.25
Trade Time: Aug 04 04:00 PM Eastern Daylight Time
Change: +3.13 (2.10%)
Prev Close: 149.12
Open: 150.23
Bid: 152.28
Ask: 152.39

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 23.32M -0.11%
MYL Mylan N.V. 7.84M -0.96%
MRK Merck & Co Inc 6.81M -0.59%
MNK Mallinckrodt PLC 6.68M -14.07%
JNJ Johnson & Johnson 6.00M -0.22%

ANAC Stock Analysis

Partner Headlines

  1. Benzinga's Top Upgrades

    Benzinga | Jul. 21, 2015 | 09:28AM EST
  2. Goldman Sachs Upgrades Anacor Pharma To Buy On 'De-Risked' Story

    Benzinga | Jul. 21, 2015 | 07:15AM EST
  3. Preliminary Results of Two Phase 3 Pivotal Studies - Report on Anacor Pharmaceuticals, ...

    Benzinga | Jul. 16, 2015 | 09:10AM EST
  4. Dermatitis Drugs Clear Rash

    IBD | Jul. 13, 2015 | 18:54PM EST
  5. Biotechs up on rash drugs

    IBD | Jul. 13, 2015 | 18:54PM EST
  6. Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug

    Benzinga | Jul. 13, 2015 | 15:29PM EST
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!